Sarasota Memorial's AI-powered program detects lung cancer early, with 75% of cases found at treatable stages.

At 43, Shira Boehler was everything the modern health narrative celebrates: disciplined, active, a 6-mile runner, and ...

Adding ivonescimab to chemotherapy prolonged progression-free survival (PFS) in previously treated advanced EGFR-mutant non-small cell lung cancer (NSCLC), but failed to significantly improve overall ...

Using lung cancer biospecimens from the Sherlock-Lung study, an international team led by National Institutes of Health (NIH) researchers, identified key factors that drive tumor evolution and ...

A first-in-human clinical trial led by an international team of researchers and published in the New England Journal of ...

Spatial maps of lung precancer and cancer cells at different points in development advance understanding of the earliest stages of lung cancer Findings highlight inflammation as a driver of lung tumor ...

In this video, Lukas Delasos, DO, an associate staff member of the Lung Cancer Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute, discusses results from the HARMONi trial ...

The likelihood of EGFR-positive lung cancer returning is largely tied to how advanced it is when first diagnosed, with lower chances in early stages and higher odds in later stages. Newer targeted ...